Success Stories: A Senior Research Fellow in the Field of Cell Biology Secures NIW Approval with our Constant Help. Thanks to Premium Processing, He even Secured EB1-A Approval within 13 days only

 

Client’s Testimonial:

“Thanks for this exciting news and your help 🙂 Thank you for making this possible.”


On October 5th, 2020 and September 16th, 2021, we received another EB2-NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approval for a Senior Research Fellow in the Field of Cell Biology (Approval Notice).


General Field: Cell Biology

Position at the Time of Case Filing: Senior Research Fellow

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: October 5th, 2020 (NIW) and September 16th, 2021 (EB-1A)

Processing Time: 13 months, 13 days (NIW) and 13 days (EB-1A) (Premium Processing Requested)


Case Summary:

An EB-2 NIW (National Interest Waiver) petition approval was granted to a senior research fellow with a Ph.D. in biochemistry from India. Before moving ahead with a client-attorney agreement, our law group evaluated his provided credentials to determine his NIW’s success. We declared that we could lead him to obtain the national interest waiver after a complete evaluation only.

Our team thus followed a full-fledged process of analyzing his background, paperwork, and the associated evidence, and were then only confident that they were enough to persuade USCIS and get him the required approval.

  • Since the method of obtaining a green card involves two steps, that is, filing an I-140 petition and an I-485 application, our client even retained us for another I-140 petition under the EB-1A (Alien of Extraordinary Ability) visa category.

We noted the following important aspects to make his case a success:

  • The 12 peer-reviewed scientific articles he published in some of the most discerning, high-impact journals in his field of cell biology.
  • An awe-inspiring record of obtaining 281 citations in other peer-reviewed journal articles
  • Cited by researchers in at least 32 countries
  • Also has conducted at least 30 reviews for at least 7 journals and conferences

Moreover, our client’s research addresses some of our nation’s and the world’s most pressing issues, including the public health burden and economic impact of diseases like cancer and COVID-19. His strong background in cell division and protein biochemistry has allowed his research to be particularly original, resulting in his success in fundamentally transforming cell biology research.

  • Furthermore, our client’s study on chromosome segregation during cell division has been recognized and supported by the National Institutes of Health (NIH) and the National Institute of General Medical Sciences. Since these were established to promote the discovery and application of knowledge “to enhance health, lengthen life, and reduce illness and disability,” this funding serves as clear evidence of the merit of our client’s work in the scientific and medical communities.

Therefore, considering the impactful articles he has published, the numerous citations his work has attained, and the funding it has been granted, have only proven him to be a noteworthy and influential member of the field.

  • Moreover, the following 2 statements are excerpted from two of the five recommendation letters submitted:

“[Client’s] research relates to the cellular mechanisms that underpin diseases affecting a significant portion of the American population…The role that cell biology plays in such a wide range of diseases that affect the US underscores the necessity of [client’s] work in the field. [Client] has consistently made vital progress in the study of cell biology and proven himself as a pioneering member of the field.”

“Understanding how cells work is fundamental to all biological sciences and biomedical research. [Client] is a researcher who is advancing the field of cell biology by researching the molecular mechanisms of cell division and chromosome segregation…In addition, [client’s] research is of value to the United States both because of the importance of advancing biological research in the country and because of the impact that cancer has on Americans, with more than 600,000 people expected to die of cancer in 2018.”

  • The totality of this evidence shows that our client is one of that small percentage who has risen to the very top of his field and has sustained both national and international acclaim. He is therefore fully qualified as an individual of extraordinary ability in his field of expertise.

We are exhilarated that our team was once again successful in persuading USCIS of the importance of our client’s research in the United States. Thus, he was granted not only NIW but also EB1-A approval in just 13 days (thanks to Premium Processing). We would sincerely like to thank him for choosing our law firm for the I-140 petitions and wish him success in his future endeavors.


North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.



If you are interested in filing the green card, please send your CV to law@wegreened.com for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.

Approval Notices: https://www.wegreened.com/eb1_niw_approvals

Success Stories: https://www.wegreened.com/blog/

Website: www.wegreened.com

Free evaluation email: law@wegreened.com

Tel: 888.666.0969 (Toll Free)


To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE


Copyright © North America Immigration Law GroupWeGreened.com, All Rights Reserved.